VONISH-M 0.2TABLET

Product Description

Product Name: VONISH-M 0.2 Tablet Composition: Voglibose (0.2mg) + Metformin (500mg) (Bi-Layered Formulation) Packaging: Blister Pack | GMP Certified | Prescription-Based Product Overview: VONISH-M 0.2 Tablet is a powerful anti-diabetic combination therapy designed for effective management of Type 2 Diabetes Mellitus. This bi-layered formulation synergizes Voglibose and Metformin to deliver enhanced glycemic control by targeting both postprandial and fasting blood glucose levels. Key Benefits: Dual-action control on blood sugar: postprandial & basal Voglibose slows carbohydrate absorption, reducing sugar spikes Metformin improves insulin sensitivity & reduces hepatic glucose output Bi-layered design ensures optimal release profile Trusted by diabetologists and general practitioners Usage & Indication: Indicated as an adjunct to diet and exercise for adults with Type 2 Diabetes not adequately controlled with Metformin monotherapy. Dosage as directed by a healthcare professional. Ideal For: Bulk pharmaceutical distributors Generic medicine exporters Retail pharmacy chains Hospital procurement managers PCD franchise companies